Yatin Suneja
Stock Analyst at Guggenheim
(4.50)
# 275
Out of 5,090 analysts
147
Total ratings
57.25%
Success rate
18.64%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Initiates: Buy | $35 | $13.06 | +167.99% | 1 | Dec 3, 2025 | |
| IFRX InflaRx | Maintains: Buy | $10 → $22 | $1.08 | +1,937.23% | 6 | Nov 10, 2025 | |
| ANAB AnaptysBio | Maintains: Buy | $90 → $100 | $44.25 | +125.99% | 14 | Nov 5, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $200 → $205 | $150.50 | +36.21% | 9 | Nov 4, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $815 → $865 | $720.55 | +20.05% | 8 | Oct 29, 2025 | |
| NMRA Neumora Therapeutics | Upgrades: Buy | $14 | $2.25 | +522.22% | 3 | Oct 27, 2025 | |
| RAPT RAPT Therapeutics | Initiates: Buy | $70 | $34.31 | +104.02% | 4 | Oct 27, 2025 | |
| ORKA Oruka Therapeutics | Initiates: Buy | $60 | $30.80 | +94.81% | 1 | Oct 27, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $155 → $350 | $255.07 | +37.22% | 3 | Oct 17, 2025 | |
| ABVX ABIVAX Société Anonyme | Maintains: Buy | $101 → $150 | $110.97 | +35.17% | 3 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $0.54 | +1,372.21% | 3 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $20 | $14.97 | +33.60% | 4 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $1,070 | $897.81 | +19.18% | 13 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $21 | $21.06 | -0.28% | 3 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $92 → $100 | $43.85 | +128.05% | 2 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $19.65 | +281.68% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $15 | $2.54 | +490.55% | 6 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $175 | $156.18 | +12.05% | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $3.73 | +597.05% | 6 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $18 | $10.52 | +71.10% | 2 | Jun 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $29 | $15.05 | +92.69% | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $12 | $14.57 | -17.64% | 4 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $3.81 | +293.70% | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $22.73 | - | 8 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $40.11 | +12.19% | 3 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 | $19.83 | +126.93% | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $27.61 | -27.55% | 6 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.44 | - | 2 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $65 | $33.45 | +94.35% | 1 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $90 | $29.27 | +207.48% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.09 | - | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $44.98 | +8.94% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $55 | $17.44 | +215.37% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $270 → $350 | $182.56 | +91.72% | 3 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.15 | - | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $17.11 | +40.27% | 1 | May 31, 2022 |
DBV Technologies
Dec 3, 2025
Initiates: Buy
Price Target: $35
Current: $13.06
Upside: +167.99%
InflaRx
Nov 10, 2025
Maintains: Buy
Price Target: $10 → $22
Current: $1.08
Upside: +1,937.23%
AnaptysBio
Nov 5, 2025
Maintains: Buy
Price Target: $90 → $100
Current: $44.25
Upside: +125.99%
Axsome Therapeutics
Nov 4, 2025
Maintains: Buy
Price Target: $200 → $205
Current: $150.50
Upside: +36.21%
Regeneron Pharmaceuticals
Oct 29, 2025
Maintains: Buy
Price Target: $815 → $865
Current: $720.55
Upside: +20.05%
Neumora Therapeutics
Oct 27, 2025
Upgrades: Buy
Price Target: $14
Current: $2.25
Upside: +522.22%
RAPT Therapeutics
Oct 27, 2025
Initiates: Buy
Price Target: $70
Current: $34.31
Upside: +104.02%
Oruka Therapeutics
Oct 27, 2025
Initiates: Buy
Price Target: $60
Current: $30.80
Upside: +94.81%
Praxis Precision Medicines
Oct 17, 2025
Maintains: Buy
Price Target: $155 → $350
Current: $255.07
Upside: +37.22%
ABIVAX Société Anonyme
Oct 10, 2025
Maintains: Buy
Price Target: $101 → $150
Current: $110.97
Upside: +35.17%
Oct 8, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $0.54
Upside: +1,372.21%
Sep 30, 2025
Maintains: Buy
Price Target: $80 → $20
Current: $14.97
Upside: +33.60%
Sep 18, 2025
Reiterates: Buy
Price Target: $1,070
Current: $897.81
Upside: +19.18%
Sep 18, 2025
Maintains: Buy
Price Target: $15 → $21
Current: $21.06
Upside: -0.28%
Sep 9, 2025
Maintains: Buy
Price Target: $92 → $100
Current: $43.85
Upside: +128.05%
Aug 18, 2025
Initiates: Buy
Price Target: $75
Current: $19.65
Upside: +281.68%
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $2.54
Upside: +490.55%
Aug 1, 2025
Maintains: Buy
Price Target: $165 → $175
Current: $156.18
Upside: +12.05%
Jun 25, 2025
Reiterates: Buy
Price Target: $26
Current: $3.73
Upside: +597.05%
Jun 10, 2025
Reinstates: Buy
Price Target: $18
Current: $10.52
Upside: +71.10%
May 9, 2025
Maintains: Buy
Price Target: $32 → $29
Current: $15.05
Upside: +92.69%
May 2, 2025
Maintains: Buy
Price Target: $18 → $12
Current: $14.57
Upside: -17.64%
Mar 26, 2025
Reiterates: Buy
Price Target: $15
Current: $3.81
Upside: +293.70%
Mar 20, 2025
Reiterates: Buy
Price Target: n/a
Current: $22.73
Upside: -
Mar 12, 2025
Reiterates: Buy
Price Target: $45
Current: $40.11
Upside: +12.19%
Jan 3, 2025
Upgrades: Buy
Price Target: $45
Current: $19.83
Upside: +126.93%
Jan 3, 2025
Downgrades: Neutral
Price Target: $20
Current: $27.61
Upside: -27.55%
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.44
Upside: -
Oct 25, 2024
Maintains: Buy
Price Target: $50 → $65
Current: $33.45
Upside: +94.35%
Feb 27, 2024
Maintains: Buy
Price Target: $72 → $90
Current: $29.27
Upside: +207.48%
Jul 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.09
Upside: -
Jun 15, 2023
Reiterates: Buy
Price Target: $49
Current: $44.98
Upside: +8.94%
May 18, 2023
Maintains: Buy
Price Target: $52 → $55
Current: $17.44
Upside: +215.37%
May 1, 2023
Upgrades: Buy
Price Target: $270 → $350
Current: $182.56
Upside: +91.72%
Oct 14, 2022
Downgrades: Neutral
Price Target: n/a
Current: $4.15
Upside: -
May 31, 2022
Initiates: Buy
Price Target: $24
Current: $17.11
Upside: +40.27%